1. C. Walton et al., “Rising Prevalence of Multiple Sclerosis worldwide: Insights from the Atlas of MS, Third Edition,” Multiple Sclerosis Journal, vol. 26, no. 14, pp. 1816–1821, 2020.
2. J. M. Wardlaw et al., “Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration,” The Lancet Neurology, vol. 12, no. 8, pp. 822–838, 2013.
3. C. Lucchinetti, W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann, “Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination,” Annals of neurology, vol. 47, no. 6, pp. 707–17, 2000.
4. Matthias Bussas et al., “Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers,” Multiple Sclerosis Journal, vol. 28, no. 6, pp. 900–909, 2021.
5. W. J. Brownlee, T. A. Hardy, F. Fazekas, and D. H. Miller, “Diagnosis of multiple sclerosis: progress and challenges,” The Lancet, vol. 389, no. 10076, pp. 1336–1346, 2017.
6. M. Filippi et al., “Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis,” Brain, vol. 118, no. 6, pp. 1593–1600, 1995.
7. M. Ward and M. D. Goldman, “Epidemiology and Pathophysiology of Multiple Sclerosis,” CONTINUUM: Lifelong Learning in Neurology, vol. 28, no. 4, pp. 988–1005, 2022.
8. M. Homssi et al., “Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI,” American Journal of Neuroradiology, vol. 44, no. 6, pp. 649–655, 2023.
9. À. Rovira et al., “MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process,” Nature Reviews Neurology, vol. 11, no. 8, pp. 471–482, 2015.
10. M. Filippi et al., “Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines,” Brain, vol. 142, no. 7, pp. 1858–1875, 2019.
11. F. L. Rosa et al., “Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: Emerging machine learning techniques and future avenues,” NeuroImage Clinical, vol. 36, pp. 103205–103205, 2022.
12. K. Juluru et al., “Integrating AI Algorithms into the Clinical Workflow,” Radiology: Artificial Intelligence, vol. 3, no. 6, p. e210013, 2021.
13. Y. Ma et al., “Multiple Sclerosis Lesion Analysis in Brain Magnetic Resonance Images: Techniques and Clinical Applications,” IEEE Journal of Biomedical and Health Informatics, vol. 26, no. 6, pp. 2680–2692, 2022.
14. R. E. Gabr et al., “Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale study,” Multiple sclerosis (Houndmills, Basingstoke, England), p. 1352458519856843, 2019.
15. S. Chakrabarty, A. Sotiras, M. Milchenko, P. LaMontagne, M. Hileman, and D. Marcus, “MRI-based Identification and Classification of Major Intracranial Tumor Types by Using a 3D Convolutional Neural Network: A Retrospective Multi-institutional Analysis,” Radiology: Artificial Intelligence, vol. 3, no. 5, p. e200301, 2021.
16. P. De et al., “Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis,” Scientific Reports, vol. 14, no. 1, 2024.
17. C. Yu, B. Mohajer, and J. Eng, “External Validation of Deep Learning Algorithms for Radiologic Diagnosis: A Systematic Review,” Radiology: Artificial Intelligence, vol. 4, no. 3, 2022.
18. C.-L. Phuah et al., “Association of Data-Driven White Matter Hyperintensity Spatial Signatures with Distinct Cerebral Small Vessel Disease Etiologies,” Neurology, vol. 99, no. 23, pp. e2535–e2547, 2022.
19. C. Tur et al., “Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique,” NeuroImage: Clinical, vol. 33, pp. 102904–102904, 2022.
20. J. Jiménez-Balado, F. Corlier, C. Habeck, Y. Stern, and T. Eich, “Effects of white matter hyperintensities distribution and clustering on late-life cognitive impairment,” Scientific Reports, vol. 12, no. 1, 2022.
21. D. Yang et al., “Segmentation of Subtraction Images for the Measurement of Lesion Change in Multiple Sclerosis,” American Journal of Neuroradiology, vol. 29, no. 2, pp. 340–346, 2008.
22. G. Cooper et al., “Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation,” Multiple Sclerosis Journal, vol. 27, no. 14, pp. 2180–2190, 2021.
23. Mário João Fartaria, T. Kober, C. Granziera, and Meritxell Bach Cuadra, “Longitudinal analysis of white matter and cortical lesions in multiple sclerosis,” NeuroImage. Clinical, vol. 23, pp. 101938–101938, 2019.
24. S. Hitziger, W. X. Ling, T. Fritz, T. D’Albis, A. Lemke, and J. Grilo, “Triplanar U-Net with lesion-wise voting for the segmentation of new lesions on longitudinal MRI studies,” Frontiers in Neuroscience, vol. 16, 2022.
25. S. P. Thakur, M. K. Schindler, M. Bilello, and S. Bakas, “Clinically Deployed Computational Assessment of Multiple Sclerosis Lesions,” Frontiers in Medicine, vol. 9, 2022.
26. M. B. Bawil, M. Shamsi, A. S. Bavil, and S. Danishvar, “Specialized gray matter segmentation via a generative adversarial network: application on brain white matter hyperintensities classification,” Frontiers in Neuroscience, vol. 18, 2024.
27. M. B. Bawil, M. Shamsi, and A. S. Bavil, “AI-Driven Multi-parametric MS Lesion Analysis from T2-FLAIR Imaging: a Clinical Decision Support Framework for Neuroradiology,” Journal of Imaging Informatics in Medicine, 2026.
28. J. Thompson et al., “Diagnosis of Multiple sclerosis: 2017 Revisions of the McDonald Criteria,” The Lancet Neurology, vol. 17, no. 2, pp. 162–173, 2018.
29. X. Lladó et al., “Segmentation of multiple sclerosis lesions in brain MRI: A review of automated approaches,” Information Sciences, vol. 186, no. 1, pp. 164–185, 2012.
30. R. Zivadinov and R. Bakshi, “Role of MRI in multiple sclerosis II: brain and spinal cord atrophy,” Frontiers in Bioscience, vol. 9, no. 1–3, pp. 647–647, 2004.
31. F. Barkhof et al., “Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis,” Brain, vol. 120, no. 11, pp. 2059–2069, 1997.
32. M. B. Bawil, M. Shamsi, A. Ghalehasadi, A. F. Jafargholkhanloo, and A. S. Bavil, "A Multiple Sclerosis MRI Dataset with Tri-Mask Annotations for Lesion Segmentation," Scientific Data, 2026.
